Michael W. Hofmann
Career history of Michael W. Hofmann
Former positions of Michael W. Hofmann
| Companies | Position | Start | End |
|---|---|---|---|
| BioReliance Manufacturing GmbH | Corporate Officer/Principal | - | - |
| University of Mannheim | Corporate Officer/Principal | - | - |
X2-Pharma GmbH
 X2-Pharma GmbH Pharmaceuticals: MajorHealth Technology X2-Pharma GmbH develops pharmaceutical products for the treatment of inflammatory diseases. It is a biopharmaceutical company that offers small molecule pharmaceuticals for the treatment of inflammatory diseases. The company is headquartered in Heidelberg, Germany. | Corporate Officer/Principal | - | - |
| Ruprecht-Karls-Universität Heidelberg | Corporate Officer/Principal | - | - |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 30/06/2000 | - |
Training of Michael W. Hofmann
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistics
International
| Germany | 5 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Health Technology |
| BioReliance Manufacturing GmbH | Health Technology |
X2-Pharma GmbH
X2-Pharma GmbH Pharmaceuticals: MajorHealth Technology X2-Pharma GmbH develops pharmaceutical products for the treatment of inflammatory diseases. It is a biopharmaceutical company that offers small molecule pharmaceuticals for the treatment of inflammatory diseases. The company is headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Michael W. Hofmann
- Experience
